Research article Special Issues

On the rate of clinical AIDS on diagnosis: The mathematical interpretation and goal for the successful control of HIV/AIDS

  • Published: 02 July 2025
  • The most widely used measurement of transmission dynamics in real time is the effective reproduction number $ R\left(t\right) $. However, in the context of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS), $ R\left(t\right) $ has not been used frequently, possibly because of the slowly progressing nature of HIV infection that limits the knowledge of recent infection events. Gaining deeper insights into the practically used epidemiological metrics of HIV/AIDS is therefore vital. Notably, in many high-income countries, including Japan, the rate of clinical AIDS on diagnosis, $ Q\left(t\right) $, has been routinely measured by calculating the proportion of newly diagnosed AIDS cases out of all new HIV infections that are diagnosed at a given calendar time. However, there has been no clear indication of whether the control of HIV/AIDS is effective in relation to this metric in Japan. In this study, we formulated the rate of clinical AIDS on diagnosis using a mathematical model and offered interpretations of it using the hazard rate of diagnosis among previously undiagnosed HIV-infected individuals. We showed that by taking the inverse of the odds of $ Q\left(t\right) $ and multiplying it by the inverse of the mean incubation period, we obtained $ \alpha \left(t\right) $, which is the hazard rate of diagnosis among undiagnosed HIV-infected individuals. We also showed that $ \alpha \left(t\right) $ can be related to the goal of the diagnosed proportion $ {P}_{0} $ among all people living with HIV. In addition to the rate of clinical AIDS on diagnosis $ Q\left(t\right) $, $ \alpha \left(t\right) $ can be calculated using a simplistic equation and can potentially act as a practical epidemiological metric for monitoring during surveillance.

    Citation: Seiko Fujiwara, Hiroshi Nishiura. On the rate of clinical AIDS on diagnosis: The mathematical interpretation and goal for the successful control of HIV/AIDS[J]. Mathematical Biosciences and Engineering, 2025, 22(8): 2105-2119. doi: 10.3934/mbe.2025077

    Related Papers:

  • The most widely used measurement of transmission dynamics in real time is the effective reproduction number $ R\left(t\right) $. However, in the context of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS), $ R\left(t\right) $ has not been used frequently, possibly because of the slowly progressing nature of HIV infection that limits the knowledge of recent infection events. Gaining deeper insights into the practically used epidemiological metrics of HIV/AIDS is therefore vital. Notably, in many high-income countries, including Japan, the rate of clinical AIDS on diagnosis, $ Q\left(t\right) $, has been routinely measured by calculating the proportion of newly diagnosed AIDS cases out of all new HIV infections that are diagnosed at a given calendar time. However, there has been no clear indication of whether the control of HIV/AIDS is effective in relation to this metric in Japan. In this study, we formulated the rate of clinical AIDS on diagnosis using a mathematical model and offered interpretations of it using the hazard rate of diagnosis among previously undiagnosed HIV-infected individuals. We showed that by taking the inverse of the odds of $ Q\left(t\right) $ and multiplying it by the inverse of the mean incubation period, we obtained $ \alpha \left(t\right) $, which is the hazard rate of diagnosis among undiagnosed HIV-infected individuals. We also showed that $ \alpha \left(t\right) $ can be related to the goal of the diagnosed proportion $ {P}_{0} $ among all people living with HIV. In addition to the rate of clinical AIDS on diagnosis $ Q\left(t\right) $, $ \alpha \left(t\right) $ can be calculated using a simplistic equation and can potentially act as a practical epidemiological metric for monitoring during surveillance.



    加载中


    [1] J. Wallinga, P. Teunis, Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures, Am. J. Epidemiol, 160 (2004), 509–516. https://doi.org/10.1093/aje/kwh255 doi: 10.1093/aje/kwh255
    [2] P. Nouvellet, S. Bhatia, A. Cori, K. E. C. Ainslie, M. Baguelin, S. Bhatt, et al., Reduction in mobility and COVID-19 transmission, Nat. Commun, 12 (2021), 1090. https://doi.org/10.1038/s41467-021-21358-2 doi: 10.1038/s41467-021-21358-2
    [3] S. M. Jung, A. Endo, A. R. Akhmetzhanov, H. Nishiura, Predicting the effective reproduction number of COVID-19: Inference using human mobility, temperature, and risk awareness, Int. J. Infect. Dis., 113 (2021), 47–54. https://doi.org/10.1016/j.ijid.2021.10.007 doi: 10.1016/j.ijid.2021.10.007
    [4] Y. Okada, S. Yamasaki, A. Nishida, R. Shibasaki, H. Nishiura, Night-time population consistently explains the transmission dynamics of coronavirus disease 2019 in three megacities in Japan, Front. Public Health, 11 (2023), 1163698. https://doi.org/10.3389/fpubh.2023.1163698 doi: 10.3389/fpubh.2023.1163698
    [5] E. J. Amundsen, H. Stigum, J. A. Røttingen, O. O. Aalen, Definition and estimation of an actual reproduction number describing past infectious disease transmission: application to HIV epidemics among homosexual men in Denmark, Norway and Sweden, Epidemiol. Infect., 132 (2004), 1139–1149. https://doi.org/10.1017/s0950268804002997 doi: 10.1017/s0950268804002997
    [6] H. Nishiura, Correcting the actual reproduction number: A simple method to estimate R(0) from early epidemic growth data, Int. J. Environ. Res. Public Health, 7 (2010), 291–302. https://doi.org/10.3390/ijerph7010291 doi: 10.3390/ijerph7010291
    [7] Y. Luo, J. Huang, Z. Teng, Q. Liu, Role of ART and PrEP treatments in a stochastic HIV/AIDS epidemic model, Math. Comput. Simul., 221 (2024), 337–357. https://doi.org/10.1016/j.matcom.2024.03.010 doi: 10.1016/j.matcom.2024.03.010
    [8] X. Zhang, T. Zheng, Y. Luo, P. F. Liu, Analysis of a reaction-diffusion AIDS model with media coverage and population heterogeneity, Electron. Res. Arch., 33 (2025), 513–536. https://doi.org/10.3934/era.2025024 doi: 10.3934/era.2025024
    [9] Y. Hao, Y. Luo, J. Huang, L. Zhang, Z. D. Teng, Analysis of a stochastic HIV/AIDS model with commercial heterosexual activity and Ornstein–Uhlenbeck process, Math. Comput. Simul., 234 (2025), 50–72. https://doi.org/10.1016/j.matcom.2025.02.020 doi: 10.1016/j.matcom.2025.02.020
    [10] H. Nishiura, S. Fujiwara, A. Imamura, T. Shirasaka, Regional variations in HIV diagnosis in Japan before and during the COVID-19 pandemic, Infect. Dis. Model., 10 (2024), 40–49. https://doi.org/10.1016/j.idm.2024.08.004 doi: 10.1016/j.idm.2024.08.004
    [11] H. Nishiura, Estimating the incidence and diagnosed proportion of HIV infections in Japan: A statistical modeling study, PeerJ, 7 (2019), e6275. https://doi.org/10.7717/peerj.6275 doi: 10.7717/peerj.6275
    [12] B. L. Keyfitz, N. Keyfitz, The McKendrick partial differential equation and its uses in epidemiology and population study, Math. Comput. Model., 26 (1997), 1–9. https://doi.org/10.1016/S0895-7177(97)00165-9 doi: 10.1016/S0895-7177(97)00165-9
    [13] R. M. Granich, C. F. Gilks, C. Dye, K. M. De Cock, B. G. Williams, Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: A mathematical model, Lancet, 373 (2009), 48–57. https://doi.org/10.1016/S0140-6736(08)61697-9 doi: 10.1016/S0140-6736(08)61697-9
    [14] K. Nah, H. Nishiura, N. Tsuchiya, X. Sun, Y. Asai, A. Imamura, Test-and-treat approach to HIV/AIDS: a primer for mathematical modeling, Theor. Biol. Med. Model., 14 (2017), 16. https://doi.org/10.1186/s12976-017-0062-9 doi: 10.1186/s12976-017-0062-9
    [15] H. Nishiura, S. Fujiwara, A. Imamura, T. Shirasaka, HIV incidence before and during the COVID-19 pandemic in Japan, Math. Biosci. Eng., 21 (2024), 4874–4885. https://doi.org/10.3934/mbe.2024215 doi: 10.3934/mbe.2024215
    [16] J. Wallinga, M. Lipsitch, How generation intervals shape the relationship between growth rates and reproductive numbers, Proc. Biol. Sci., 274 (2007), 599–604. https://doi.org/10.1098/rspb.2006.3754 doi: 10.1098/rspb.2006.3754
    [17] J. L. Boldson, J. L. Jensen, J. Sogaard, M. Sorensen, On the incubation time distribution and the Danish AIDS data, J. R. Stat. Soc. A, 151 (1988), 42–43. https://doi.org/10.2307/2982183 doi: 10.2307/2982183
    [18] A. Muñoz, J. Xu, Models for the incubation of AIDS and variations according to age and period, Stat. Med., 15 (1996), 2459–2473. https://doi.org/10.1002/(SICI)1097-0258(19961130)15:22<2459::AID-SIM453>3.0.CO;2-Q doi: 10.1002/(SICI)1097-0258(19961130)15:22<2459::AID-SIM453>3.0.CO;2-Q
    [19] R. Brookmeyer, J. J. Goedert, Censoring in an epidemic with an application to haemophilia-associated AIDS, Biometrics, 45 (1989), 325–335. https://doi.org/10.2307/2532057 doi: 10.2307/2532057
    [20] F. Shi, J. Zhang, S. Chen, X. Yang, Z. Li, S. Weissman, et al., Multi-level Factors Associated with HIV late presentation with advanced disease and delay time of diagnosis in South Carolina, 2005–2019, AIDS Behav., 28 (2024), 3205–3216. https://doi.org/10.1007/s10461-024-04414-y doi: 10.1007/s10461-024-04414-y
    [21] Z. V. Rueda, L. Arroyave, M. Herrera, A. E. Singh, S. Skinner, C. Spence, et al., Evolution and possible explanations for the trends in new HIV diagnoses in Alberta, Saskatchewan, and Manitoba, compared to the rest of Canada, 1985–2022, J. Assoc. Med. Microbiol. Infect. Dis. Can., 10 (2025). https://doi.org/10.3138/jammi-2024-0026
    [22] H. I. Hall, J. Halverson, D. P. Wilson, B. Suligoi, M. Diez, S. Le Vu, et al., Late diagnosis and entry to care after diagnosis of human immunodeficiency virus infection: A country comparison, PLoS One, 8 (2013), e77763. https://doi.org/10.1371/journal.pone.0077763 doi: 10.1371/journal.pone.0077763
    [23] National AIDS Trust, UK HIV statistics, National AIDS Trust (2024). https://nat.org.uk/about-hiv/hiv-statistics/
    [24] S. J. Jeong, C. Italiano, R. Chaiwarith, O. T. Ng, S. Vanar, A. Jiamsakul, et al., Late Presentation into Care of HIV Disease and Its Associated Factors in Asia: Results of TAHOD, AIDS Res. Hum. Retroviruses, 32 (2016), 255–261. https://doi.org/10.1089/AID.2015.0058 doi: 10.1089/AID.2015.0058
    [25] H. Tang, Y. Mao, W. Tang, J. Han, J. Xu, J. Li, Late for testing, early for antiretroviral therapy, less likely to die: Results from a large HIV cohort study in China, 2006–2014, BMC Infect. Dis., 18 (2018), 272. https://doi.org/10.1186/s12879-018-3158-x doi: 10.1186/s12879-018-3158-x
    [26] Ministry of Health Singapore, Update on the HIV/AIDS situation in Singapore, 2023 (January–October 2023), Ministry of Health, (2024). https://www.moh.gov.sg/newsroom/update-on-hiv-aids-situation-in-singapore-2023-%28december-2023%29
    [27] C. S. Wong, L. Wei, Y. S. Kim, HIV Late Presenters in Asia: Management and Public Health Challenges, AIDS Res. Treat., 2023 (2023), 9488051. https://doi.org/10.1155/2023/9488051 doi: 10.1155/2023/9488051
    [28] Committee of AIDS Trends, Ministry of Health, Labour and Welfare, Quarterly report 2024, AIDS Prevention Information Network (2024). https://api-net.jfap.or.jp/status/japan/index.html
  • Reader Comments
  • © 2025 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(1056) PDF downloads(54) Cited by(0)

Article outline

Figures and Tables

Figures(4)  /  Tables(1)

Other Articles By Authors

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog